ArticlePloS one2025
Elevated blood urea nitrogen-to-creatinine ratio predicts short-term mortality in intensive care unit patients with ischemic stroke: Evidence from a multicenter cohort.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe blood urea nitrogen-to-creatinine ratio (BUCR) has emerged as a potential biomarker for predicting the prognosis of Intensive Care Unit (ICU) patients. However, its relationship with short-term mortality in patients with ischemic stroke (IS) remains controversial. This study aimed to investigate the association between BUCR and 28-day in-hospital mortality in ICU IS patients.
methodsThis retrospective cohort study utilized data from the eICU Collaborative Research Database (2014--2015). A total of 2,702 ICU patients with IS were included. The BUCR was calculated on the basis of initial blood urea nitrogen and serum creatinine levels obtained within the first 24 hours of ICU admission. The association between BUCR and 28-day in-hospital mortality was assessed via Cox proportional hazards regression models. Restricted cubic spline analysis was performed to evaluate potential nonlinear relationships. Sensitivity analyses-including complete-case analysis, multiple imputation, propensity score matching, and E-value estimation-were conducted to assess the robustness of the findings.
resultsThe mean age at baseline was 68.59 years (SD: 14.29), and 313 patients (11.58%) died within 28 days of hospitalization. Compared with Q1, BUCR in Q3 was significantly associated with 28-day in-hospital mortality (HR = 1.616; 95% CI: 1.173, 2.226). After full adjustment for potential confounders, a linear relationship was observed between BUCR and mortality risk. Each unit increase in BUCR was associated with a 1.4% increase in the hazard of death (HR = 1.014; 95% CI: 1.002, 1.027; P = 0.021). Sensitivity analyses confirmed the robustness of this association.
conclusionAn elevated BUCR is an independent predictor of 28-day in-hospital mortality in ICU patients with ischemic stroke. This finding provides compelling evidence to address existing inconsistencies in the field, suggesting that BUCR may serve as a simple and effective biomarker for identifying high-risk patients with severe IS.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.